Jane Street
PACB icon

Jane Street’s Pacific Biosciences PACB Stock Holding History

Jane Street’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236K Sell
178,500
-128,500
-42% -$230K ﹤0.01% 9770
2025
Q4 		$574K Buy
307,000
+16,800
+6% +$32.3K ﹤0.01% 7378
2025
Q3 		$371K Buy
290,200
+274,600
+1,760% +$372K ﹤0.01% 8489
2025
Q2 		$19.3K Sell
15,600
-425,100
-96% -$491K ﹤0.01% 9364
2025
Q1 		$520K Sell
440,700
-1,194,900
-73% -$1.83M ﹤0.01% 6793
2024
Q4 		$2.99M Buy
1,635,600
+1,546,600
+1,738% +$3.02M ﹤0.01% 3444
2024
Q3 		$151K Sell
89,000
-18,700
-17% -$30.7K ﹤0.01% 8814
2024
Q2 		$148K Buy
107,700
+89,500
+492% +$181K ﹤0.01% 8583
2024
Q1 		$68.3K Sell
18,200
-373,200
-95% -$2.19M ﹤0.01% 8674
2023
Q4 		$3.84M Buy
391,400
+44,700
+13% +$366K ﹤0.01% 3245
2023
Q3 		$2.89M Sell
346,700
-68,400
-16% -$782K ﹤0.01% 3432
2023
Q2 		$5.52M Buy
415,100
+86,700
+26% +$1.05M ﹤0.01% 2588
2023
Q1 		$3.8M Buy
328,400
+163,800
+100% +$1.63M ﹤0.01% 2813
2022
Q4 		$1.35M Sell
164,600
-17,300
-10% -$149K ﹤0.01% 4495
2022
Q3 		$1.06M Buy
181,900
+55,700
+44% +$320K ﹤0.01% 5320
2022
Q2 		$558K Sell
126,200
-317,900
-72% -$1.93M ﹤0.01% 6529
2022
Q1 		$4.04M Buy
444,100
+316,800
+249% +$3.65M ﹤0.01% 3407
2021
Q4 		$2.6M Sell
127,300
-57,400
-31% -$1.39M ﹤0.01% 3956
2021
Q3 		$4.72M Sell
184,700
-40,700
-18% -$1.21M ﹤0.01% 2833
2021
Q2 		$7.88M Sell
225,400
-240,000
-52% -$6.98M ﹤0.01% 1999
2021
Q1 		$15.5M Buy
465,400
+202,100
+77% +$7.07M 0.01% 1187
2020
Q4 		$6.83M Buy
+263,300
New +$4.47M ﹤0.01% 1758
2016
Q4 		– Sell
-10,100
Closed -$90K – 4453
2016
Q3 		$90K Sell
10,100
-100
-1% -$836 ﹤0.01% 3859
2016
Q2 		$72K Buy
+10,200
New +$93.2K ﹤0.01% 3930

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jane Street's PACB Position: Q1 2026 in Review

Jane Street reduced its Pacific Biosciences (PACB) stake by 7.4% in Q1 2026, selling an estimated $198K and leaving 1,390,070 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #5260.

Jane Street first reported a position in PACB in Q3 2013 and has held it in 31 quarters since. The position peaked at $6.66M in Q1 2021. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Jane Street held 1,390,070 shares of Pacific Biosciences worth $1.83M as of Q1 2026.
  • Jane Street sold 110,448 Pacific Biosciences shares in Q1 2026, an estimated $198K.
  • Pacific Biosciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5260 holding.
  • Jane Street first reported a position in Pacific Biosciences in Q3 2013 and has held it in 31 quarters since.
  • Jane Street's Pacific Biosciences position peaked at $6.66M in Q1 2021.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.